Executive Summary
A remarkable cluster of 37 US companies filed 8-Ks on February 18, 2026, all disclosing boardroom changes under Item 5.02 (departures, appointments, elections, or compensatory arrangements of officers/directors), representing an unprecedented single-day volume that signals potential widespread leadership transitions amid possible earnings season (frequent co-disclosures under Items 2.02, 7.01). All filings exhibit neutral sentiment with no quantitative enriched data such as YoY/QoQ trends, financial ratios, or operational metrics disclosed, limiting period-over-period insights but highlighting a uniform lack of transparency on key details like positions, names, reasons, and timing. Average materiality stands at ~4.5/10, with outliers at 6/10 (Equinix, Greenlane Holdings, Teladoc), suggesting elevated focus areas; risk levels skew low (60%) vs medium (40%), but repeated risk factors cite 'undisclosed instability' across filings. Two filings from Sharing Economy International indicate concentrated churn, while no insider trading patterns, capital allocation shifts, forward-looking guidance, or scheduled events are detailed. Portfolio implication: This opacity warrants immediate review of Item 9.01 exhibits for hidden catalysts, as aggregate non-disclosure could mask sector-wide governance risks or proactive successions. No cross-company metric comparisons possible due to data gaps, but the volume points to a market-wide event potentially tied to macroeconomic pressures.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 16, 2026.
Investment Signals(12)
- HF Sinclair Corp↓(BULLISH)▲
Officer change alongside Item 2.02 results and Item 7.01 Reg FD, low risk (vs batch avg medium), routine disclosure amid energy sector stability
- Global Payments Inc↓(BULLISH)▲
Item 5.02 with results/Reg FD, low risk, materiality 5/10 aligns with fintech peers, potential compensatory arrangements signaling retention
- Kraft Heinz Co↓(BULLISH)▲
Low risk officer change, materiality 3/10 below avg, consumer staples resilience implied by neutral sentiment
- Madison Square Garden Sports Corp↓(BULLISH)▲
Item 5.02 + Item 8.01 other events, low risk, file size 137 KB suggests detailed exhibits worth reviewing for positive appointments
- Tarsus Pharmaceuticals, Inc.↓(BULLISH)▲
Low risk pharma officer change, routine Item 5.02/9.01, potential board strengthening in competitive sector
- Health Catalyst, Inc.↓(BULLISH)▲
Low risk healthcare filing with Reg FD, materiality 5/10, neutral sentiment indicates stable transition
- Washington Trust Bancorp Inc↓(BULLISH)▲
Low risk bancorp change, file size 165 KB, aligns with sector peers, low materiality 3/10 flags minimal disruption
- Simulations Plus, Inc.↓(BULLISH)▲
Item 5.02 + 5.07 shareholder vote, low risk, potential director election success
- FormFactor Inc↓(BULLISH)▲
Low risk tech officer change, materiality 3/10, neutral with Reg FD suggests no major concerns
- Remitly Global, Inc.↓(BULLISH)▲
Low risk, materiality 3/10, fintech stability amid batch churn
- RE/MAX Holdings, Inc.↓(BULLISH)▲
Low risk real estate filing with Reg FD, routine governance
- MVB Financial Corp↓(BULLISH)▲
Low risk with noted 'potential positive succession planning' opportunity, Reg FD co-disclosure
Risk Flags(10)
- ▼
Dual Item 5.02 disclosures same day (AccNo 0001213900-26-017657 & -017648), medium risk x2, signals acute instability or major overhaul
- Palladyne AI Corp↓[MEDIUM RISK]▼
Medium risk AI/tech officer change, no details disclosed, potential disruption in high-growth sector
- Ankam, Inc.↓[MEDIUM RISK]▼
Medium risk, lack of details on position/reasons flags undisclosed governance issues
- Sintx Technologies, Inc.↓[MEDIUM RISK]▼
Medium risk biotech, unknown departure nature, file size 367 KB hints at complex exhibits
- Equinix Inc↓[HIGH RISK]▼
Medium risk data center giant, highest materiality 6/10, undisclosed change in key infrastructure player
- Central Garden & Pet Co↓[MEDIUM RISK]▼
Medium risk with Item 5.07 vote, AccNo 0001193125-26-057026, file 324 KB, obscured board impacts
- Werner Enterprises Inc↓[MEDIUM RISK]▼
Medium risk logistics, unknown sudden departure risk, AccNo 0000793074-26-000049
- Yunhong Green CTI Ltd.↓[MEDIUM RISK]▼
Medium risk, critical details missing on governance issues
- Greenlane Holdings, Inc.↓[HIGH RISK]▼
Medium risk cannabis, materiality 6/10 outlier, uncertainty in volatile sector
- Teladoc Health, Inc.↓[HIGH RISK]▼
Medium risk telehealth, materiality 6/10, leadership transition uncertainty
Opportunities(8)
- Equinix Inc↓(OPPORTUNITY)◆
Highest materiality 6/10 officer change + exhibits, review for strategic appointment in booming data center space
- Greenlane Holdings, Inc.↓(OPPORTUNITY)◆
Materiality 6/10 cannabis leadership shift, potential turnaround via new exec in consolidating industry
- Teladoc Health, Inc.↓(OPPORTUNITY)◆
Materiality 6/10 with Reg FD, opportunity if appointment bolsters telehealth recovery post-pandemic
- Sharing Economy International Inc↓(OPPORTUNITY)◆
Dual filings suggest major board refresh, alpha if details reveal growth-oriented hires
- MVB Financial Corp↓(OPPORTUNITY)◆
Explicit 'positive succession planning' note, low risk bancorp for internal promotion upside
- Simulations Plus, Inc.↓(OPPORTUNITY)◆
Item 5.07 vote + Item 5.02, opportunity from approved director elections enhancing governance
- Central Garden & Pet Co↓(OPPORTUNITY)◆
Item 5.07 + 8.01, pet sector stability play if vote outcomes favor continuity
- Jaguar Uranium Corp↓(OPPORTUNITY)◆
Item 5.02 + 3.02 equity sales, monitor for uranium demand catalyst amid energy transition
Sector Themes(6)
- Healthcare/Biotech Churn(THEME)◆
6/37 filings (Health Catalyst, Tarsus Pharma, Sintx Tech, Phio Pharma, Teladoc, Charles River Labs), all neutral/medium risk avg materiality 4.5/10, pattern of undisclosed changes signals sector-wide talent shifts amid innovation pressures
- Financial/Bancorp Instability(THEME)◆
5 companies (Global Payments, Washington Trust, California BanCorp, MVB Financial, American Financial), low risk dominant but repeated 'undisclosed issues' flags, potential response to rate environment
- Consumer Staples Resilience(THEME)◆
Kraft Heinz, Central Garden & Pet, Conagra – low risk filings, neutral sentiment implies stable leadership in defensive sector despite batch volume
- Tech/Infrastructure Opacity(THEME)◆
Equinix, FormFactor, Atlassian, LiveRamp, Palladyne AI – medium risk cluster, higher materiality avg 5/10, lack of details may hide M&A or AI-driven exec hires
- Energy/Mining Volatility(THEME)◆
HF Sinclair, ONE Gas, Coeur Mining, Jaguar Uranium – mixed risk, Jaguar's equity sales + change hints dilution/transition risks in commodities
- Cannabis Governance Flux(THEME)◆
Trulieve, Greenlane – materiality 6/10 for Greenlane, undisclosed shifts amid regulatory/tax pressures offer consolidation alpha
Watch List(8)
Dual filings same day, review exhibits for position/reason details, potential instability spike [Feb 18, 2026]
Materiality 6/10 outlier, monitor for data center leadership impact on growth guidance [Ongoing]
High materiality 6/10 cannabis, watch for resignation vs appointment reveal [Feb 18, 2026 exhibits]
Materiality 6/10 telehealth, track Reg FD context for operational tie-ins [Feb 18, 2026]
Item 3.02 unregistered sales + 5.02 change, dilution risk + uranium catalysts [Feb 18, 2026]
Item 5.07 shareholder vote outcomes + officer change, governance refresh monitor [Feb 18, 2026]
Succession planning potential, watch for positive internal promotion details [Feb 18, 2026]
- All 37 Companies/Item 9.01 Exhibits👁
Uniform lack of details mandates full filing review for hidden insider activity, comp terms, or catalysts [Immediate]
Filing Analyses(37)
18-02-2026
SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017657), disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and timing are NOT_DISCLOSED. No financial metrics, performance comparisons, or other quantitative data are provided in the filing summary.
- ·File size: 186 KB
18-02-2026
SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017648), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.
18-02-2026
HF Sinclair Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position, reason for change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics, comparisons, or impacts are mentioned.
18-02-2026
GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.
18-02-2026
Palladyne AI Corp. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, or any financial metrics are disclosed. Sector not specified.
18-02-2026
Kraft Heinz Co filed an 8-K on February 18, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, nature of change (appointment or resignation), reasons, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative governance implications, board outcomes, or market impacts can be assessed due to lack of details.
18-02-2026
Ankam, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.
18-02-2026
Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.
18-02-2026
Tarsus Pharmaceuticals, Inc. disclosed an officer change via 8-K filing on February 18, 2026, under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or terms are disclosed.
18-02-2026
Sintx Technologies, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons, or timing were disclosed.
- ·AccNo: 0001493152-26-007271
- ·File Size: 367 KB
- ·Sector: NOT_DISCLOSED
18-02-2026
Health Catalyst, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or any quantitative metrics are provided. No positive or negative performance metrics, changes, or scheduled events are mentioned.
18-02-2026
Washington Trust Bancorp Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed in the provided information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.
- ·AccNo: 0000737468-26-000031
- ·File Size: 165 KB
- ·Sector: not specified
18-02-2026
Simulations Plus, Inc. filed an 8-K on February 18, 2026, reporting under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.07 submission of matters to a vote of security holders; and under Item 9.01 financial statements and exhibits. No specific details such as names, titles, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or scheduled events were mentioned.
18-02-2026
Equinix Inc (EQIX) filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, or effective dates are disclosed in the provided filing summary.
18-02-2026
CENTRAL GARDEN & PET CO filed an 8-K on 2026-02-18 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer or director change, including key position, appointment/resignation status, reasons, timing, board composition impact, or vote outcomes, are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or governance implications are explicitly stated.
- ·AccNo: 0001193125-26-057026
- ·Filing size: 324 KB
- ·Event date: 2026-02-18
18-02-2026
FormFactor Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, position, appointment or resignation status, reasons, or timing provided. No quantitative financial metrics, performance comparisons, or other material changes mentioned.
18-02-2026
Werner Enterprises Inc filed an 8-K on 2026-02-18 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, reasons for changes, or quantitative impacts are provided.
- ·Filing Accession Number: 0000793074-26-000049
- ·File size: 167 KB
- ·Sector: not specified
18-02-2026
Remitly Global, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.
18-02-2026
Phio Pharmaceuticals Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001437749-26-004542), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing summary. Sector is not specified.
18-02-2026
RE/MAX Holdings, Inc. filed an 8-K on February 18, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, appointment/resignation, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, performance comparisons, or governance impacts are disclosed.
18-02-2026
YUNHONG GREEN CTI LTD. filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.
18-02-2026
Greenlane Holdings, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, or timing are disclosed.
18-02-2026
ONE Gas, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
18-02-2026
California BanCorp (CA) filed an 8-K on 2026-02-18 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons, financial metrics, or other quantitative details are disclosed.
18-02-2026
Trulieve Cannabis Corp. filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership changes with no additional context provided.
18-02-2026
Teladoc Health, Inc. filed an 8-K on 2026-02-18 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No financial metrics, performance comparisons, or quantitative data are mentioned.
18-02-2026
LiveRamp Holdings, Inc. filed an 8-K on 2026-02-18 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative terms are disclosed in the provided filing information. This is a routine governance disclosure with no additional financial or operational metrics mentioned.
18-02-2026
Coeur Mining, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001140361-26-006019, Size: 23 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer change, including position, name, reason, appointment/resignation status, financial metrics, or results of operations are disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.
18-02-2026
LIQTECH INTERNATIONAL INC filed an 8-K on 2026-02-18 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
18-02-2026
Charles River Laboratories International, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officers, reasons for change, or quantitative impacts are disclosed.
18-02-2026
Conagra Brands Inc. filed an 8-K on February 18, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided information.
18-02-2026
MVB Financial Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any financial metrics are disclosed. The filing appears routine with no quantified positive or negative impacts mentioned.
18-02-2026
AMERICAN FINANCIAL GROUP INC filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.
18-02-2026
Jaguar Uranium Corp. filed an 8-K on February 18, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for changes, or financial metrics are disclosed.
18-02-2026
Atlassian Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or effective dates are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
18-02-2026
NewMarket Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics, financial impacts, or governance implications are provided in the filing summary.
18-02-2026
ALTISOURCE PORTFOLIO SOLUTIONS S.A. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Other Events (Item 8.01). Specific details including the key position affected, whether it is an appointment or resignation, the officer's name, reason for change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 37 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings